Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy
Chemotherapeutic drugs chronically administered to tumor-bearing mice, using a frequent schedule at doses substantially lower than the maximum tolerated dose (MTD) (i.e., metronomic dosing), can cause sustained and potent antiangiogenic effects by targeting the endothelial cells of newly growing tum...
Enregistré dans:
| Publié dans: | Proc Natl Acad Sci U S A |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
National Academy of Sciences
2003
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC240719/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14561896/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.2135406100 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|